Literature DB >> 27913181

Squarate-based carbocyclic nucleosides: Syntheses, computational analyses and anticancer/antiviral evaluation.

Meijun Lu1, Qing-Bin Lu2, John F Honek3.   

Abstract

Squaric acid and its derivatives are versatile synthons and have demonstrated applications in medicinal chemistry, notably as non-classical bioisosteric replacements for functional groups such as carboxylic acids, alpha-amino acids, urea, guanidine, peptide bonds and phosphate/pyrophosphate linkages. Surprisingly, no reports have appeared concerning its possible application as a nucleobase substitute in nucleosides. A preliminary investigation of such an application is reported herein. 3-Amino-4-((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)amino-cyclobut-3-ene-1,2-dione, 3-((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)amino-4-methoxycyclobut-3-ene-1,2-dione, and 3-hydroxy-4-((1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl)amino-cyclobut-3-ene-1,2-dione sodium salt were synthesized. Computational analyses of their structures and preliminary antitumor and antiviral screening results are reported.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anticancer; Antiviral; Bioisostere; Carbocyclic; Nucleoside; Squaric acid

Mesh:

Substances:

Year:  2016        PMID: 27913181     DOI: 10.1016/j.bmcl.2016.11.058

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Synthesis and evaluation of 3'-[18F]fluorothymidine-5'-squaryl as a bioisostere of 3'-[18F]fluorothymidine-5'-monophosphate.

Authors:  D Brickute; A Beckley; L Allott; M Braga; C Barnes; K J Thorley; E O Aboagye
Journal:  RSC Adv       Date:  2021-03-29       Impact factor: 4.036

2.  Squaramide-Tethered Sulfonamides and Coumarins: Synthesis, Inhibition of Tumor-Associated CAs IX and XII and Docking Simulations.

Authors:  Giulia Arrighi; Adrián Puerta; Andrea Petrini; Francisco J Hicke; Alessio Nocentini; Miguel X Fernandes; José M Padrón; Claudiu T Supuran; José G Fernández-Bolaños; Óscar López
Journal:  Int J Mol Sci       Date:  2022-07-12       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.